JARMeC reports strong earnings growth for fiscal year 2025
Japan Animal Referral Medical Center (JARMeC) [TSE: 6039] announced its consolidated financial results for the year ended March 31, 2025, showcasing robust growth in both revenue and profitability. Net sales increased by 23.6% to JPY 5,277 million, while operating profit rose by 45.1% to JPY 720 million. The company's ordinary profit climbed 47.1% to JPY 720 million, and profit attributable to owners of parent jumped 54.5% to JPY 520 million. Earnings per share reached JPY 201.12. JARMeC forecasts continued growth for the fiscal year ending March 31, 2026, projecting net sales of JPY 5,810 million and earnings per share of JPY 203.11. The company plans to pay an annual dividend of JPY 40.00 per share for the fiscal year ending March 31, 2026.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Japan Animal Referral Medical Center publishes news
Free account required • Unsubscribe anytime